Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016
International Clinical Trials’ Day Cromos Pharma is proud to celebrate International Day of Clinical Trials and congratulates its partners and employees! On this day, in 1747, the Scottish physician James Lind held his first study on 12 sailors suffering from scurvy. Based on the results, Lind’s suggestions were published in “A Treatise of the Scurvy” in 1753. (more –www.jameslindlibrary.org).
Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016
Cromos™ Pharma launches risk-sharing partnerships program with biotech and pharma companies PORTLAND, OR–(Marketwired – Dec 15, 2014) – Cromos™ Pharma, an international full-service CRO announced today the implementation of a risk-sharing platform partnering with biotech, pharma and device companies that have promising drug, biologics or medical device technologies. Cromos™ Pharma offers several unique business partnership algorithms through its risk-sharing model, including clinical research program conduct in
Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016
As the debate about “strategic” vs. “transactional” relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player As the debate about “strategic” vs. “transactional” relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player. Please follow the link to the whitepaper that may provide some additional insight into this contentious issue.

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM